Evaluating the Age-Based Recommendations for Long-Term Follow-Up in Breast Cancer.
Annemieke WitteveenLinda de MunckCatharina G M Groothuis-OudshoornGabe S SonkePhilip M PoortmansLiesbeth J BoersmaMarjolein L SmidtIngrid M H VliegenMaarten J IJzermanSabine SieslingPublished in: The oncologist (2020)
The current age-based recommendations for breast cancer follow-up after 5 years are suboptimal and do not reflect the actual risk of recurrent disease. This results in situations in which women with higher risks actually receive less follow-up than those with a lower risk of recurrence. Alternative cutoffs could be a start toward risk-based follow-up and thereby more efficient allocation of resources. However, age, or any single risk factor, is not able to capture the risk differences and therefore is not sufficient for determining follow-up. More risk factors should be taken into account for truly individualizing follow-up based on the risk for recurrence.
Keyphrases